Related Experiment Video

Updated: Jun 10, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Re-evaluating Biochemical Recurrence Definitions After Radiation Therapy: Time to Move Beyond "Phoenix"?

Mario Terlizzi1, Guillaume Ploussard2, Gaëlle Fiard3

  • 1Radiation Therapy Department, Gustave Roussy, Villejuif.

International Journal of Radiation Oncology, Biology, Physics
|June 8, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids
05:39

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Published on: April 5, 2024

Related Experiment Videos

Last Updated: Jun 10, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids
05:39

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Published on: April 5, 2024

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Articles linked to this work by shared authors, journal, and citation graph.

An overlooked opportunity? SBRT + ADT for aggressive prostate cancer in the elderly.

Clinical and translational radiation oncology·2026

How to optimise prostate SBRT: ESTRO clinical practice consensus recommendations.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused Sampling.

European urology focus·2026

Deep learning prediction of chemo-immunotherapy response using tumor perfusion ultrasound images.

Frontiers in artificial intelligence·2026

PSA persistence in the PSMA PET era: reassessing a risk factor after radical prostatectomy.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Mapping radiosensitivity in glioblastoma using MR elastography and biomechanical modeling.

Scientific reports·2026

Proton Radiation for Locally Advanced Breast Cancer: Evolution and Techniques.

International journal of radiation oncology, biology, physics·2026

Local control and outcomes associated with proton spine hypofractionated radiation therapy.

International journal of radiation oncology, biology, physics·2026

Initial Experience with Special Medical Physics Consultations for Proton Re-Irradiation.

International journal of radiation oncology, biology, physics·2026

Multimodal Artificial Intelligence System for Risk-Adapted Cancer Survivorship Surveillance: A Multicenter Target Trial Emulation.

International journal of radiation oncology, biology, physics·2026

A Phase I Study of Cyclical Hypofractionated Palliative Radiotherapy (Quad Shot) for Central Lung Tumors in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC): Results from the PROMISE 006 Trial Thoracic Quad Shot RT in Stage IV NSCLC.

International journal of radiation oncology, biology, physics·2026

Model-aided quantification of patient-specific benefit in mitigating radiation induced lymphopenia by particle therapy of cancer.

International journal of radiation oncology, biology, physics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us